Market Tracker

03/24 5:16pm ET

Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

4.57
Delayed Data
As of Mar 24
 +0.10 / +2.24%
Today’s Change
2.54
Today|||52-Week Range
7.15
-24.96%
Year-to-Date
How I'd Play Biotech Buyout Rumors
Mar 24 / TheStreet.com - Paid Partner Content
Synergy Pharmaceuticals: Approval, Now What?
Mar 13 / MotleyFool.com - Paid Partner Content
How I'd Play Biotech Buyout Rumours
Mar 24 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close4.47
Today’s open4.50
Day’s range4.48 - 4.59
Volume4,878,834
Average volume (3 months)6,181,319
Market cap$997.3M
Dividend yield--
Data as of 4:00pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-9.01%
Earnings growth (this year)+57.52%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book24.14

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...+0.65+3.14%
XNCRXencor Inc+0.82+3.46%
FOLDAmicus Therapeutics ...+0.10+1.40%
AIMTAimmune Therapeutics...+0.04+0.18%
Data as of 4:00pm ET, 03/24/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$198.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Gary S. Jacob
Senior Vice President-
Clinical Operations
Laura Barrow
Corporate headquarters
New York, New York

Forecasts